Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check2 days agoChange DetectedA new version entry appears in the record history, while the main study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check30 days agoChange DetectedIntroducing a government-operating-status notice and a new version tag (v3.2.0) while removing the old version tag (v3.1.0). The change primarily communicates updated operating status and a software version upgrade.SummaryDifference13%

- Check38 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check52 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the old v3.0.1 tag and the 'Back to Top' element were removed.SummaryDifference0.8%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.8%

- Check66 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference11%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.